# REGENERON PHARMACEUTICALS, INC. (REGN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from REGENERON PHARMACEUTICALS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/REGN/mda/fy2025/): filed 2026-02-04; accession 0000872589-26-000008 (https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/REGN/mda/fy2024/): filed 2025-02-05; accession 0001804220-25-000011 (https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/regn-20241231.htm)
- [FY 2023 MD&A](/company/REGN/mda/fy2023/): filed 2024-02-05; accession 0001804220-24-000009 (https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/regn-20231231.htm)
- [FY 2022 MD&A](/company/REGN/mda/fy2022/): filed 2023-02-06; accession 0001804220-23-000008 (https://www.sec.gov/Archives/edgar/data/872589/000180422023000008/regn-20221231.htm)
- [FY 2021 MD&A](/company/REGN/mda/fy2021/): filed 2022-02-07; accession 0001804220-22-000007 (https://www.sec.gov/Archives/edgar/data/872589/000180422022000007/regn-20211231.htm)

Back to /company/REGN/